The groundbreaking rise of Sildenafil presented a considerable prospect for the market, but its exclusivity has ended, creating a complex landscape. Generic versions have entered the market , eroding revenues and putting a strain on profit margins . While major healthcare companies maintain a stake in this area, the potential seems unclear by fierc